Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

 1,868.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 2,568.00
  • 52 Week Low: 1,637.00
  • Currency: UK Pounds
  • Shares Issued: 66.03m
  • Volume: 0
  • Market Cap: £1,233.49m
  • RiskGrade: 128

Monday broker round-up

By Caoimhe Toman

Date: Monday 02 Jul 2018

LONDON (ShareCast) - (Sharecast News) - Polar Capital Holdings: Canaccord downgrades to hold with a target price of 725p.
Chemring Group: Berenberg reiterates buy with a target price of 255

Xaar: Canaccord reiterates buy with a target price of 700p.

James Cropper: Canaccord initiates buy with a target price of 1,700p.

Consort Medical: Shore Capital Markets downgrades to hold.

Eve Sleep: Peel Hunt downgrades to hold.

Melrose: Peel Hunt reiterates buy with a target price of 240p.

Weir: Liberum reiterates buy with a target price of 2,400p.

Sirius Minerals: Liberum reiterates buy with a target price of 60p.

Genus: Kepler Cheuvreux reiterates hold with a target price of 2,470p.

Jupiter Fund Management: Numis reiterates hold with a target price of 441p.

Micro Focus: Credit Suisse reiterates neutral with a target price of 1,200p.

Northgate: Berenberg reiterates hold with a target price of 395p.

GVC Holdings: Berenberg reiterates buy with a target price of 1,370p.

Eddie Stobart Logistics: Berenberg reiterates buy with a target price of 200p.

Compass Group: Berenberg reiterates buy with a target price of 1,800p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 1,868.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 2,568.00
52 Week Low 1,637.00
Volume 0
Shares Issued 66.03m
Market Cap £1,233.49m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
96.04% below the market average96.04% below the market average96.04% below the market average96.04% below the market average96.04% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
53.64% below the market average53.64% below the market average53.64% below the market average53.64% below the market average53.64% below the market average
18.52% above the sector average18.52% above the sector average18.52% above the sector average18.52% above the sector average18.52% above the sector average
Income
86.4% below the market average86.4% below the market average86.4% below the market average86.4% below the market average86.4% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Growth
67.9% below the market average67.9% below the market average67.9% below the market average67.9% below the market average67.9% below the market average
64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 29-Feb-24 09-Nov-23
Paid 28-Mar-24 08-Dec-23
Amount 10.30p 21.70p

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page